000 | 01253 a2200373 4500 | ||
---|---|---|---|
005 | 20250512153239.0 | ||
264 | 0 | _c19711215 | |
008 | 197112s 0 0 eng d | ||
022 | _a0033-3190 | ||
024 | 7 |
_a10.1159/000286071 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKnopp, W | |
245 | 0 | 0 |
_aMan's tripartite brain and psychosomatic medicine. _h[electronic resource] |
260 |
_bPsychotherapy and psychosomatics _c1970 |
||
300 |
_a130-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAcute Disease |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 |
_aBrain _xphysiopathology |
650 | 0 | 4 |
_aEmotions _xdrug effects |
650 | 0 | 4 | _aEvaluation Studies as Topic |
650 | 0 | 4 |
_aHaloperidol _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aNeurophysiology |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aPsychiatric Status Rating Scales |
650 | 0 | 4 |
_aPsychophysiologic Disorders _xphysiopathology |
650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
650 | 0 | 4 |
_aTourette Syndrome _xdrug therapy |
650 | 0 | 4 |
_aTrifluoperazine _xtherapeutic use |
773 | 0 |
_tPsychotherapy and psychosomatics _gvol. 18 _gno. 1 _gp. 130-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1159/000286071 _zAvailable from publisher's website |
999 |
_c5287932 _d5287932 |